Evidence map›Paper›PMID 19880857›Full record

ArticleHuman molecular genetics2010

A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon.

Xiao-Fei Kong, Guillaume Vogt, Ariane Chapgier, Christophe Lamaze, Jacinta Bustamante, Carolina Prando, Anny Fortin, Anne Puel, Jacqueline Feinberg, Xin-Xin Zhang and 8 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Human molecular genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. The role of interferon-γ in cardiovascular disease: an update.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2020
    Review
  4. Article
  5. Inherited human IFN-γ deficiency underlies mycobacterial disease.The Journal of clinical investigation · 2020
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 4 countries.

Xiao-Fei KongThese authors contributed equally to this work.
Guillaume Vogt
Ariane Chapgier
Christophe Lamaze
Jacinta Bustamante
Carolina Prando
Anny Fortin
Anne Puel
Jacqueline Feinberg
Xin-Xin Zhang
Pauline Gonnord
Ulla M Pihkala-Saarinen
Mikko Arola
Petra Moilanen
Laurent Abel
Matti Korppi
Stéphanie Boisson-Dupuis
Jean-Laurent Casanova
Délégation Paris 5 · FRBiologie cellulaire et Cancer · FRTampere University Hospital · FIHelsinki University Hospital · FIKuopio University Hospital · FIRockefeller University · USRuijin Hospital · CN

Funding

TRANSFORMING TRANSLATIONAL SCIENCE AND EDUCATION TO BENEFIT HUMAN HEALTHUL1RR024143 · NCRR · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY · 2006 to 2011
$49.1M
NCRR NIH HHS 5UL1 RR 024143-03NCRR NIH HHS UL1 RR024143
6 · The paper itself

Abstract

IFN-gammaR1 deficiency is a genetic etiology of Mendelian susceptibility to mycobacterial diseases, and includes two forms of complete recessive deficiency, with or without cell surface expression, and two forms of partial deficiency, dominant or recessive. We report here a novel form of partial and recessive Interferon gamma receptor 1 (IFN-gammaR1) deficiency, which is almost as severe as complete deficiency. The patient is homozygous for a mutation of the initiation codon (M1K). No detectable expression and function of IFN-gammaR1 were found in the patient's fibroblasts. However, IFN-gammaR1 expression was found to be impaired, but not abolished, on the EBV-transformed B cells, which could respond weakly to IFN-gamma. The mechanism underlying this weak expression involves leaky translation initiation at both non-AUG codons and the third AUG codon at position 19. It results in the residual expression of IFN-gammaR1 protein of normal molecular weight and function. The residual IFN-gamma signaling documented in this novel form of partial IFN-gammaR1 deficiency was not ubiquitous and was milder than that seen in other forms of partial IFN-gammaR1 deficiency, accounting for the more severe clinical phenotype of the patient, which was almost as severe as that of patients with complete deficiency.

Indexed as

Codon, InitiatorGerm-Line MutationB-LymphocytesCell LineCells, CulturedChildFemaleFibroblastsGenetic Predisposition to DiseaseHumansInterferon-gammaInterferon gamma ReceptorMutation, MissenseMycobacterium InfectionsReceptors, InterferonSpecies SpecificityCodon, InitiatorInterferon-gammaInterferon gamma ReceptorReceptors, Interferon

Identifiers

PMID19880857
PMCPMC2800780
OpenAlexW2163667076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.